Dr Alexandros Georgiou

Dr Alex Georgiou is a Consultant Medical Oncologist at Guy's and St Thomas' NHS Hospital (GSTT) and King's College Hospitals London, UK. He specialises in the treatment of thoracic malignancies: lung cancer, mesothelioma and thymic cancers.  Dr Georgiou currently serves as the clinical service lead for all Systemic Anti-Cancer Therapies (SACT) and the lung cancer and mesothelioma clinical trials lead at GSTT. He is the UK chief investigator and principal investigator at GSTT in multiple international clinical trials investigating novel treatments for lung cancer and mesothelioma. He is also an honorary senior lecturer at King's College London (KCL) and leads on academic research at KCL and GSTT aiming to improve the early diagnosis, treatment, and outcomes for lung cancer patients. He completed his medical oncology training at the Royal Marsden Hospital in London, 2012-2019. During his training he secured competitive Cancer Research UK (CRUK) funding, which supported his successful three-year PhD (2015-2018) at the Institute of Cancer Research (ICR) London. His doctoral research explored the mechanisms of resistance to targeted anti-cancer therapies, earning him a Merit award from the European Society of Medical Oncology Congress (ESMO) in 2018 and a University of London scholarship in 2019. He has an extensive publication record in oncology and in particular lung cancer and has been invited to speak at both national and international oncology conferences. Additionally, he provides clinical advice to 'EGFR Positive UK', a UK lung cancer charity. Dr Georgiou's publications can be found here: https://www.researchgate.net/profile/Alexandros-Georgiou

Lung Cancer, mesothelioma, Thymic malignancies, immunotherapy, chemotherapy, targeted therapies, clinical trials.